Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 6 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
5(83.3%)
Phase 2
1(16.7%)
6Total
N/A(5)
Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials
NCT05801536Not ApplicableCompleted

TCES for Upper Limb Function in Cervical SCI

Role: collaborator

NCT05504200Not ApplicableCompleted

Transcutaneous Spinal Cord Stimulation With Bladder and Pelvic Floor Muscle Training

Role: collaborator

NCT04604951Not ApplicableRecruiting

Below the Belt: Non-invasive Neuromodulation to Treat Bladder, Bowel, and Sexual Dysfunction Following Spinal Cord Injury

Role: collaborator

NCT04132596Not ApplicableCompleted

Spinal Stimulation in Chronic Spinal Cord Injury

Role: collaborator

NCT05522920Not ApplicableUnknown

Spinal Stimulation for Chronic Complete Tetraplegia

Role: collaborator

NCT00656149Phase 2Completed

In-home Telerehabilitation for Quadriplegic Hand Function

Role: collaborator

All 6 trials loaded